Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Change in Inventory (2019 - 2025)

Historic Change in Inventory for Marimed (MRMD) over the last 7 years, with Q3 2025 value amounting to $1.2 million.

  • Marimed's Change in Inventory fell 6832.64% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 8657.38%. This contributed to the annual value of $8.2 million for FY2024, which is 4036.71% up from last year.
  • Latest data reveals that Marimed reported Change in Inventory of $1.2 million as of Q3 2025, which was down 6832.64% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Marimed's Change in Inventory ranged from a high of $3.8 million in Q3 2024 and a low of -$1.5 million during Q4 2024
  • In the last 5 years, Marimed's Change in Inventory had a median value of $1.3 million in 2025 and averaged $1.3 million.
  • Per our database at Business Quant, Marimed's Change in Inventory crashed by 443521.92% in 2021 and then soared by 76024.1% in 2024.
  • Over the past 5 years, Marimed's Change in Inventory (Quarter) stood at -$1.2 million in 2021, then skyrocketed by 195.27% to $1.2 million in 2022, then dropped by 5.74% to $1.1 million in 2023, then plummeted by 235.06% to -$1.5 million in 2024, then soared by 181.71% to $1.2 million in 2025.
  • Its Change in Inventory was $1.2 million in Q3 2025, compared to $1.3 million in Q2 2025 and $453000.0 in Q1 2025.